Hyaluronic Acid Receptor-Mediated Nanomedicines and Targeted Therapy (Small Methods 10/2024)

IF 10.7 2区材料科学 Q1 CHEMISTRY, PHYSICAL

Small Methods Pub Date : 2024-10-16 DOI:10.1002/smtd.202470062

Qiuhong Ouyang, Ying Zhao, Kunyao Xu, Yuechen He, Meng Qin

引用次数: 0

Abstract

Inside Back Cover

In article number 2400513, Qin and co-workers review the hyaluronic acid (HA) receptor-mediated nanomedicines and targeted therapy. HA exhibits multiple endogenous cellular receptors. Based on ligand-receptor interactions, HA-modified nanomedicines can target and bind to overexpressed cellular receptors, which are widely used in the treatment of diseases such as tumors and inflammation.

Abstract Image

查看原文本刊更多论文

透明质酸受体介导的纳米药物和靶向治疗（小方法 10/2024）

封底内页在编号为 2400513 的文章中，Qin 及其合作者回顾了透明质酸（HA）受体介导的纳米药物和靶向治疗。透明质酸具有多种内源性细胞受体。基于配体与受体之间的相互作用，HA修饰的纳米药物可以靶向并结合过表达的细胞受体，广泛应用于肿瘤和炎症等疾病的治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Small Methods Materials Science-General Materials Science

CiteScore

17.40

自引率

1.60%

发文量

347

期刊介绍： Small Methods is a multidisciplinary journal that publishes groundbreaking research on methods relevant to nano- and microscale research. It welcomes contributions from the fields of materials science, biomedical science, chemistry, and physics, showcasing the latest advancements in experimental techniques. With a notable 2022 Impact Factor of 12.4 (Journal Citation Reports, Clarivate Analytics, 2023), Small Methods is recognized for its significant impact on the scientific community. The online ISSN for Small Methods is 2366-9608.